New thrush treatment shows promise in early trial
NCT ID NCT07405853
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a product called pHyph for treating thrush (a vaginal yeast infection) in adult women. The goal is to see if pHyph reduces symptoms like itching, burning, and irritation. 48 women will either use pHyph daily for 6 days or receive no treatment, and researchers will compare their symptoms after a week.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVOVAGINAL CANDIDIASIS (VVC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTC
Uppsala, 75237, Sweden
-
CTC Stockholm
Solna, Sweden
-
CTC, Ebbe Park
Linköping, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.